IL-23 orchestrating immune cell activation in arthritis

Area of Science:

• Immunology
• Cytokine Biology
• Rheumatology

Background:

• Interleukin-23 (IL-23) is a pro-inflammatory cytokine central to innate and adaptive immunity.
• It promotes T helper 17 (Th17) cell differentiation, a key factor in rheumatic disease pathogenesis.
• Pre-clinical models highlight IL-23's critical role in arthritis development.

Discussion:

• IL-23-induced Th17 cells secrete IL-17A and other cytokines, contributing to synovial and skin inflammation in psoriatic arthritis (PsA).
• The role of IL-23 in rheumatoid arthritis (RA) pathogenesis is also suggested.
• Therapeutic strategies targeting IL-23 have demonstrated efficacy in PsA treatment.

Key Insights:

• IL-23 is a critical cytokine in the development and maintenance of inflammatory arthritis.
• Th17 cells, regulated by IL-23, are key mediators of inflammation in conditions like PsA.
• Targeting IL-23 is an effective therapeutic strategy for PsA.

Outlook:

• Further research is needed to establish the efficacy of IL-23 inhibition in rheumatoid arthritis (RA).
• Investigating IL-23's precise role in RA pathogenesis may reveal new therapeutic avenues.
• Continued exploration of IL-23 targeted therapies holds potential for managing inflammatory arthritic conditions.